Breaking these groups according to sex, consistent with pS1292-LRRK2/Tsg101 measurements, male carriers with PD had significantly higher phosphorylation at the 1292 residue than carriers without PD (11.5% versus 6.4%, respectively, p=0.0239 Fig. 4a2). This evidence concerns the gene TSG101 and Parkinson disease.